Seeking Alpha24d
Structure Therapeutics: Potential To Have Best-In-Class GLP-1 Agonist For Obesity Patients
Oral small molecule GIPR drug program ... then the goal would be to combine them with GLP-1 agonist GSBR-1290 to treat patients with obesity. The third risk to consider would be in terms of ...
Outsourcing-pharma15d
Competitors race to launch GLP-1 drugs amid soaring weight loss demand
Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...
Business Wire1mon
Response Pharmaceuticals Announces Enrollment of First Patients in a Phase 2 Study Evaluating RDX-002, a Novel Small Molecule iMTP Inhibitor, in Patients Discontinuing GLP-1 ...
“There is a significant and growing unmet need in patients coming off GLP-1 agonists who rapidly regain ... and gut-specific small molecule inhibitor of intestinal microsomal triglyceride ...
BioSpace11d
Novo Nordisk Signs $285M GLP-1 Deal With Danish Neighbor Ascendis
In a deal worth up to $285 million initially for the lead program, Novo Nordisk will gain access to Ascendis’ TransCon ...